{"public_id":"cl_c3ccc2313372b5a7d18905c4af7de15f","status":"active","superseded_by_public_id":null,"corpus_id":10565127,"text":"Gefitinib improved disease-related symptoms in patients with advanced non-small cell lung cancer persisting after chemotherapy.","confidence":0.98,"paper":{"corpus_id":10565127,"title":"Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial.","url":"https://sah.borca.ai/papers/10565127"},"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.98,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_14dbff488680166233197f67a900b84b","name":"non-small cell lung cancer","description":"A lung cancer subtype studied in patients with advanced disease.","types":["condition"],"url":"https://sah.borca.ai/concepts/co_14dbff488680166233197f67a900b84b"},{"public_id":"co_3f73ea690a19072f47d43023dd5b67aa","name":"gefitinib","description":"An oral epidermal growth factor receptor tyrosine kinase inhibitor used as the study drug.","types":["drug","therapy"],"url":"https://sah.borca.ai/concepts/co_3f73ea690a19072f47d43023dd5b67aa"},{"public_id":"co_6b2252d0ef498cc16b1435067231d5b0","name":"chemotherapy","description":"Prior systemic cancer treatment that patients had already received before enrollment.","types":["treatment"],"url":"https://sah.borca.ai/concepts/co_6b2252d0ef498cc16b1435067231d5b0"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_c3ccc2313372b5a7d18905c4af7de15f"}